Pharmacological Treatment of Advanced, Persistent or Metastatic Endometrial Cancer: State of the Art and Perspectives of Clinical Research for the Special Issue “Diagnosis and Management of Endometrial Cancer”

SIMPLE SUMMARY: Patients with metastatic or recurrent endometrial cancer (EC) not suitable for surgery and/or radiotherapy are candidates for pharmacological treatment with unsatisfactory clinical outcomes. The combination of carboplatin + paclitaxel is the standard first-line chemotherapy, whereas...

Descripción completa

Detalles Bibliográficos
Autores principales: Gadducci, Angiolo, Cosio, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699529/
https://www.ncbi.nlm.nih.gov/pubmed/34944775
http://dx.doi.org/10.3390/cancers13246155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699529/
https://www.ncbi.nlm.nih.gov/pubmed/34944775
http://dx.doi.org/10.3390/cancers13246155

Ejemplares similares